These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 23451774)

  • 1. Recalcitrant pemphigus vulgaris: aseptic meningitis associated with intravenous immunoglobulin therapy and successful treatment with rituximab.
    Ventura F; Rocha J; Fernandes JC; Machado A; Brito C
    Int J Dermatol; 2013 Apr; 52(4):501-2. PubMed ID: 23451774
    [No Abstract]   [Full Text] [Related]  

  • 2. Is it time to re-evaluate the treatment of pemphigus?
    Leventhal JS; Sanchez MR
    J Drugs Dermatol; 2012 Oct; 11(10):1200-6. PubMed ID: 23134985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood pemphigus vulgaris successfully treated with rituximab.
    Kanwar AJ; Sawatkar GU; Vinay K; Hashimoto T
    Indian J Dermatol Venereol Leprol; 2012; 78(5):632-4. PubMed ID: 22960821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug induced aseptic meningitis caused by intravenous immunoglobulin therapy.
    Mullane D; Williams L; Merwick A; Tobin WO; McGuigan C
    Ir Med J; 2012 Jun; 105(6):182-3. PubMed ID: 22973657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients.
    Kim MR; Kim HC; Kim SC
    Dermatology; 2011; 223(2):182-8. PubMed ID: 22025028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human intravenous immunoglobulin-induced aseptic meningitis: a case report.
    Chaabane A; Hamzaoui A; Aouam K; Klai R; Fredj NB; Boughattas NA; Mahjoub S
    J Clin Pharmacol; 2012 Feb; 52(2):279-81. PubMed ID: 21257801
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of a single-cycle alternative dosing regimen for rituximab for recalcitrant pemphigus: a case series of 9 patients.
    Matsukura S; Knowles SR; Walsh S; Shear NH
    Arch Dermatol; 2012 Jun; 148(6):734-9. PubMed ID: 22351790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current therapy of the pemphigus group.
    Kasperkiewicz M; Schmidt E; Zillikens D
    Clin Dermatol; 2012; 30(1):84-94. PubMed ID: 22137231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of severe pemphigus vulgaris of the scalp with adjuvant rituximab and immunoadsorption.
    Kamphausen I; Schulze F; Schmidt E; Zillikens D; Kunz M
    Eur J Dermatol; 2012; 22(6):786-7. PubMed ID: 23114083
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjuvant rituximab in the treatment of pemphigus vulgaris: a phase II clinical trial.
    Balighi K; Daneshpazhooh M; Khezri S; Mahdavi-nia M; Hajiseyed-javadi M; Chams-Davatchi C
    Int J Dermatol; 2013 Jul; 52(7):862-7. PubMed ID: 23789604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness and safety of rituximab in pemphigus vulgaris].
    Alonso Sánchez A; García Rodríguez S; López Avila A; Rabell Iñigo S
    Farm Hosp; 2010; 34(2):98-9. PubMed ID: 20304370
    [No Abstract]   [Full Text] [Related]  

  • 12. Rituximab in pemphigus.
    Kanwar AJ; Vinay K
    Indian J Dermatol Venereol Leprol; 2012; 78(6):671-6. PubMed ID: 23075635
    [No Abstract]   [Full Text] [Related]  

  • 13. Rituximab for pemphigus vulgaris.
    Joly P; D'Incan M; Musette P
    N Engl J Med; 2007 Feb; 356(5):521; author reply 521-2. PubMed ID: 17267915
    [No Abstract]   [Full Text] [Related]  

  • 14. [[Treatment of therapy resistant pemphigus vulgaris with rituximab and immunoglobulins].
    Mühlhoff C; Megahed M
    Hautarzt; 2007 Nov; 58(11):924-6. PubMed ID: 17952393
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-Term Remissions in Recalcitrant Pemphigus Vulgaris.
    Ahmed AR; Kaveri S; Spigelman Z
    N Engl J Med; 2015 Dec; 373(27):2693-4. PubMed ID: 26716930
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of immunological parameters in patients with pemphigus vulgaris following rituximab and IVIG therapy.
    Feldman RJ; Christen WG; Ahmed AR
    Br J Dermatol; 2012 Mar; 166(3):511-7. PubMed ID: 21967407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin.
    Ahmed AR; Spigelman Z; Cavacini LA; Posner MR
    N Engl J Med; 2006 Oct; 355(17):1772-9. PubMed ID: 17065638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of pemphigus in pediatric patients.
    Gürcan H; Mabrouk D; Razzaque Ahmed A
    Minerva Pediatr; 2011 Aug; 63(4):279-91. PubMed ID: 21909064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired haemophilia treated successfully with rituximab in a patient with pemphigus vulgaris.
    Chiba T; Tsuji G; Mitoma H; Takahara M; Moroi Y; Miyamoto T; Furue M
    Haemophilia; 2013 Mar; 19(2):e98-9. PubMed ID: 23419110
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment strategies for pemphigus vulgaris in Japan.
    Hashimoto T
    Expert Opin Pharmacother; 2008 Jun; 9(9):1519-30. PubMed ID: 18518782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.